Summit Global Investments’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-443
| Closed | -$274K | – | 637 |
|
|
2024
Q3 | $274K | Sell |
443
-1
| -0.2% | -$619 | 0.02% | 433 |
|
|
2024
Q2 | $246K | Sell |
444
-160
| -26% | -$88.6K | 0.02% | 444 |
|
|
2024
Q1 | $351K | Sell |
604
-749
| -55% | -$435K | 0.03% | 382 |
|
|
2023
Q4 | $718K | Sell |
1,353
-39
| -3% | -$20.7K | 0.05% | 280 |
|
|
2023
Q3 | $704K | Buy |
1,392
+303
| +28% | +$153K | 0.05% | 282 |
|
|
2023
Q2 | $568K | Sell |
1,089
-3
| -0.3% | -$1.57K | 0.04% | 318 |
|
|
2023
Q1 | $629K | Buy |
1,092
+283
| +35% | +$163K | 0.05% | 315 |
|
|
2022
Q4 | $445K | Buy |
809
+9
| +1% | +$4.95K | 0.04% | 335 |
|
|
2022
Q3 | $406K | Buy |
800
+7
| +0.9% | +$3.55K | 0.04% | 354 |
|
|
2022
Q2 | $431K | Sell |
793
-18
| -2% | -$9.78K | 0.04% | 343 |
|
|
2022
Q1 | $479K | Buy |
811
+194
| +31% | +$115K | 0.04% | 340 |
|
|
2021
Q4 | $412K | Buy |
617
+25
| +4% | +$16.7K | 0.03% | 400 |
|
|
2021
Q3 | $338K | Buy |
592
+4
| +0.7% | +$2.28K | 0.03% | 375 |
|
|
2021
Q2 | $298K | Sell |
588
-121
| -17% | -$61.3K | 0.02% | 461 |
|
|
2021
Q1 | $324K | Buy |
709
+113
| +19% | +$51.6K | 0.02% | 447 |
|
|
2020
Q4 | $277K | Buy |
596
+105
| +21% | +$48.8K | 0.03% | 230 |
|
|
2020
Q3 | $217K | Buy |
+491
| New | +$217K | 0.02% | 237 |
|
|
2018
Q2 | – | Sell |
-3,736
| Closed | -$771K | – | 320 |
|
|
2018
Q1 | $771K | Sell |
3,736
-123
| -3% | -$25.4K | 0.12% | 90 |
|
|
2017
Q4 | $733K | Sell |
3,859
-3,301
| -46% | -$627K | 0.11% | 116 |
|
|
2017
Q3 | $1.36M | Buy |
7,160
+3,630
| +103% | +$687K | 0.21% | 70 |
|
|
2017
Q2 | $616K | Buy |
3,530
+780
| +28% | +$136K | 0.18% | 107 |
|
|
2017
Q1 | $422K | Buy |
2,750
+250
| +10% | +$38.4K | 0.14% | 172 |
|
|
2016
Q4 | $353K | Buy |
+2,500
| New | +$353K | 0.13% | 192 |
|